Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.715 USD | +0.52% | +2.85% | -19.97% |
Apr. 08 | Replimune Group Provides Interim Results for Skin Cancer Therapy | MT |
Mar. 26 | Replimune Group, Inc. Announces Management Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.97% | 410M | |
+24.76% | 46.71B | |
+48.83% | 41.8B | |
-1.00% | 41.52B | |
-5.86% | 29.55B | |
+10.97% | 25.78B | |
-20.51% | 19.26B | |
+2.38% | 12.14B | |
-2.74% | 12.08B | |
+28.38% | 11.98B |
- Stock Market
- Equities
- REPL Stock
- News Replimune Group, Inc.
- HC Wainwright Adjusts Replimune Group's Price Target to $50 From $48, Maintains Buy Rating